Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila), which is readying to start phase 3 clinical trials, claimed that its investigational candidate ZyCoV-D can remain stable even at room temperature for
ZyCoV-D shot can remain stable at room temperature: Zydus Cadila chairman
The company plans to apply for approval once it finishes phase 3 trials
 "Vaccine")
Premium
ZyCoV-D is India's first DNA plasmid vaccine
Topics : Coronavirus Coronavirus Vaccine Pankaj Patel
First Published: Dec 12 2020 | 5:38 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com
